InvestorsHub Logo
Followers 4
Posts 338
Boards Moderated 0
Alias Born 09/03/2016

Re: None

Friday, 10/19/2018 5:23:51 PM

Friday, October 19, 2018 5:23:51 PM

Post# of 399705
looking through some players on the phase 3 trial for Isradipine, could these be potentially some of our buyout people in the group?

Disclosure: Acadia Abbvie Anavex Allergan Avid Civitas Accorda GE Medical Eli Lilly Cynapsus Ibsen IMPAX Merz Inc National Parkinson Foundation Navidea Sanofi Pfizer Sunovion TEVA UCB Pharma Voyager US World Meds. Dr. Simuni has received research support from Civitas, Acorda, Biogen, Roche Neuroderm. Dr. Holloway has nothing to disclose. Dr. Oakes has nothing to disclose. Dr. Biglan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly, Company. Dr. Lungu has nothing to disclose.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News